Please assess the completion status of the following clinical trial:

Trial Title: 12-month Study of AMG 073 in Renal Osteodystrophy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 18 years of age of greater~* Using effective contraceptive measures~* iPTH greater than or equal to 300 pg/mL~* Serum Calcium greater than or equal to 8.4 mg/dL; Hemoglobin greater than 9~* Stable hemodialysis for 1 month prior to day 1~Exclusion Criteria:~* Any unstable medical condition~* Pregnant or nursing women Recent parathyroidectomy~* Change in Vitamin D therapy~* Recent MI, Seizure, Malignancy, GI Disorder~* Inability to swallow tablets

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- AMG 073 (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).